IRTC News and Press, iRhythm Technologies Inc. From 03/06/23

SAN FRANCISCO, March 06, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health company focused on creating trusted solutions that detect, predict, and prevent disease, recently presented the results of multiple new studies at the American College of C...

iRhythm continues to expand its strong body of clinical and scientific evidence with new research presented by leading clinical investigators at the conference Highlights include a retrospective analysis of comparative effectiveness between ambulatory monitors for arrhythmia diagnosis ...

iRhythm Technologies, Inc. (IRTC) Q4 2022 Earnings Conference Call February 23, 2023 16:30 ET Company Participants Stephanie Zhadkevich - Director of Investor Relations Quentin Blackford - President & Chief Executive Officer Brice Bobzien - Chief Financial Officer ...

iRhythm Technologies press release ( NASDAQ: IRTC ): Q4 Non-GAAP EPS of -$0.59 beats by $0.02 . Revenue of $112.62M (+37.7% Y/Y) beats by $2.34M . For further details see: iRhythm Technologies Non-GAAP EPS of -$0.59 beats by $0.02, revenue of $112.62M beats by $2...

SAN FRANCISCO, Feb. 23, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months and full year ended December...

SAN FRANCISCO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the fourth quarter and f...

Wells Fargo has initiated iRhythm Technologies ( NASDAQ: IRTC ) with an outperform rating saying it has the potential to double its US penetration in the ambulatory cardiac monitoring market ("ACM") by 2027. The firm has a $150 price target (42% upside based on Monday's close). An...

Summary Investors bid up iRhythm Technologies in early January seeing it push to new highs. The upside was short-lived, however, and could have been a sucker's rally. Market generated data adds substance to this, and objective price studies indicate downside targets to $80. The ...

SAN FRANCISCO, Jan. 09, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced preliminary fourth quarter operational highlights and a business up...

SAN FRANCISCO, Dec. 27, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced the company will be participating in the upcoming 41 st Annual ...